Cargando…
Patterns of diagnostic marker assessment in adult diffuse glioma: a survey of the European Confederation of Neuropathological Societies (Euro-CNS)
The 2016 update of the WHO classification has introduced an integrated diagnostic approach that incorporates both tumor morphology and molecular information. This conceptual change has far-reaching implications, especially for neuropathologists who are in the forefront of translating molecular marke...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312234/ https://www.ncbi.nlm.nih.gov/pubmed/27966427 http://dx.doi.org/10.5414/NP301009 |
_version_ | 1782508166921060352 |
---|---|
author | Woehrer, Adelheid Kristensen, Bjarne W. Vital, Anne Hainfellner, Johannes A. |
author_facet | Woehrer, Adelheid Kristensen, Bjarne W. Vital, Anne Hainfellner, Johannes A. |
author_sort | Woehrer, Adelheid |
collection | PubMed |
description | The 2016 update of the WHO classification has introduced an integrated diagnostic approach that incorporates both tumor morphology and molecular information. This conceptual change has far-reaching implications, especially for neuropathologists who are in the forefront of translating molecular markers to routine diagnostic use. Adult diffuse glioma is a prototypic example for a group of tumors that underwent substantial regrouping, and it represents a major workload for surgical neuropathologists. Hence, we conducted a survey among members of the European Confederation of Neuropathological Societies (Euro-CNS) in order to assess 1) the extent to which molecular markers have already been incorporated in glioma diagnoses, 2) which molecular techniques are in daily use, and 3) to set a baseline for future surveys in this field. Based on 130 responses from participants across 40 nations neuropathologists uniformly rate molecular marker testing as highly relevant and already incorporate molecular information in their diagnostic assessments. At the same time however, the survey documents substantial differences in access to crucial biomarkers and molecular techniques across geographic regions and within individual countries. Concerns are raised concerning the validity of test assays with MGMT, 1p19q, and ATRX; being perceived as most problematic. Neuropathologists advocate the need for international harmonization of standards and consensus guidelines, and the majority is willing to actively engage in interlaboratory trials aiming at quality control (Figure 1). |
format | Online Article Text |
id | pubmed-5312234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dustri-Verlag Dr. Karl Feistle |
record_format | MEDLINE/PubMed |
spelling | pubmed-53122342017-03-08 Patterns of diagnostic marker assessment in adult diffuse glioma: a survey of the European Confederation of Neuropathological Societies (Euro-CNS) Woehrer, Adelheid Kristensen, Bjarne W. Vital, Anne Hainfellner, Johannes A. Clin Neuropathol Research Article The 2016 update of the WHO classification has introduced an integrated diagnostic approach that incorporates both tumor morphology and molecular information. This conceptual change has far-reaching implications, especially for neuropathologists who are in the forefront of translating molecular markers to routine diagnostic use. Adult diffuse glioma is a prototypic example for a group of tumors that underwent substantial regrouping, and it represents a major workload for surgical neuropathologists. Hence, we conducted a survey among members of the European Confederation of Neuropathological Societies (Euro-CNS) in order to assess 1) the extent to which molecular markers have already been incorporated in glioma diagnoses, 2) which molecular techniques are in daily use, and 3) to set a baseline for future surveys in this field. Based on 130 responses from participants across 40 nations neuropathologists uniformly rate molecular marker testing as highly relevant and already incorporate molecular information in their diagnostic assessments. At the same time however, the survey documents substantial differences in access to crucial biomarkers and molecular techniques across geographic regions and within individual countries. Concerns are raised concerning the validity of test assays with MGMT, 1p19q, and ATRX; being perceived as most problematic. Neuropathologists advocate the need for international harmonization of standards and consensus guidelines, and the majority is willing to actively engage in interlaboratory trials aiming at quality control (Figure 1). Dustri-Verlag Dr. Karl Feistle 2017 2016-12-14 /pmc/articles/PMC5312234/ /pubmed/27966427 http://dx.doi.org/10.5414/NP301009 Text en © Dustri-Verlag Dr. K. Feistle http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Woehrer, Adelheid Kristensen, Bjarne W. Vital, Anne Hainfellner, Johannes A. Patterns of diagnostic marker assessment in adult diffuse glioma: a survey of the European Confederation of Neuropathological Societies (Euro-CNS) |
title | Patterns of diagnostic marker assessment in adult diffuse glioma: a survey of the European Confederation of Neuropathological Societies (Euro-CNS) |
title_full | Patterns of diagnostic marker assessment in adult diffuse glioma: a survey of the European Confederation of Neuropathological Societies (Euro-CNS) |
title_fullStr | Patterns of diagnostic marker assessment in adult diffuse glioma: a survey of the European Confederation of Neuropathological Societies (Euro-CNS) |
title_full_unstemmed | Patterns of diagnostic marker assessment in adult diffuse glioma: a survey of the European Confederation of Neuropathological Societies (Euro-CNS) |
title_short | Patterns of diagnostic marker assessment in adult diffuse glioma: a survey of the European Confederation of Neuropathological Societies (Euro-CNS) |
title_sort | patterns of diagnostic marker assessment in adult diffuse glioma: a survey of the european confederation of neuropathological societies (euro-cns) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312234/ https://www.ncbi.nlm.nih.gov/pubmed/27966427 http://dx.doi.org/10.5414/NP301009 |
work_keys_str_mv | AT woehreradelheid patternsofdiagnosticmarkerassessmentinadultdiffusegliomaasurveyoftheeuropeanconfederationofneuropathologicalsocietieseurocns AT kristensenbjarnew patternsofdiagnosticmarkerassessmentinadultdiffusegliomaasurveyoftheeuropeanconfederationofneuropathologicalsocietieseurocns AT vitalanne patternsofdiagnosticmarkerassessmentinadultdiffusegliomaasurveyoftheeuropeanconfederationofneuropathologicalsocietieseurocns AT hainfellnerjohannesa patternsofdiagnosticmarkerassessmentinadultdiffusegliomaasurveyoftheeuropeanconfederationofneuropathologicalsocietieseurocns |